Factors influencing cognitive function, sleep, and quality of life in individuals with systemic lupus erythematosus: A review of the literature

Clinical Neuropsychologist

Volumn 18, Issue 1, 2004, Pages 132-147

  Sweet, Jerry J ^a,b,d   Doninger, Nicholas A ^c   Zee, Phyllis C ^a   Wagner, Lynne I ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b EVANSTON NORTHWESTERN HEALTHCARE   (United States)

^c UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^d ABPP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEREBROVASCULAR DISEASE; COGNITION; COGNITIVE DEFECT; CONFUSION; DISEASE ACTIVITY; HUMAN; NEUROIMAGING; NEUROLOGICAL COMPLICATION; NEUROPSYCHOLOGY; PSYCHOSIS; QUALITY OF LIFE; REVIEW; SEIZURE; SLEEP PARAMETERS; SYSTEMIC LUPUS ERYTHEMATOSUS;

COGNITION; COGNITION DISORDERS; DIAGNOSTIC IMAGING; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; NEUROPSYCHOLOGICAL TESTS; QUALITY OF LIFE; REVIEW LITERATURE; SLEEP;

EID: 4444311387     PISSN: 13854046     EISSN: None     Source Type: Journal    
DOI: 10.1080/13854040490507244     Document Type: Review

References (107)

1. Aaronson, L.S., Teel, C.S., Cassmeyer, V., Neuberger, G.B., Pallikkathayil, L., Pierce, J., Press, A.N., Williams, P.D., & Wingate, A. (1999). Defining and measuring fatigue. Image: The Journal of Nursing Scholarship, 31, 45-50.
2. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature. (1999). The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis and Rheumatism, 42, 599-608 (and Appendix C).
3. Adams, S., Dammers, P., Saia, T., Brantley, P., & Gaydos, G. (1994). Stress, depression, and anxiety predict average symptom severity and daily symptom fluctuation in systemic lupus erythematosus. Journal of Behavioral Medicine, 17, 459-477.
4. Afeltra, A., Garzia, P., Mitterhofer, A.P., Vadacca, M., Galluzzo, S., Del Porto, F., Finamore, L., Pascucci, S., Gasparini, M., Lagana, B., Caccavo, D., Ferri, G.M., Amoroso, A., & Francia, A. (2003). Neuropsychiatric lupus syndromes: Relationship with antiphospholipid antibodies. Neurology, 61, 108-110.
5. Ainiala, H., Loukkola, J., Peltola, J., Korpela, M., & Hietaharju, A. (2001). The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology, 57, 496-500
6. Bedard, M.A., Montplaisir, J., Malo, J., Richer, F., & Rouleau, I. (1993). Persistent neuropsychological deficits and vigilance impairment in sleep apnea syndrome after treatment with continuous positive airways pressure (CPAP). Journal of Clinical and Experimental Neuropsychology, 15, 330-341.
7. Benz, R.L., Pressman, M.R., Hovick, E.T., & Peterson, D.D. (1999). A preliminary study of the effects of correction of anemia with recombinant human erythropoietin therapy on sleep, sleep disorders, and daytime sleepiness in hemodialysis patients (The SLEEPO study). American Journal Kidney Disease, 34, 1089-1095.
8. Benz, R.L., Pressman, M.R., Hovick, E.T., & Peterson, D.D. (2000). Potential novel predictors of mortality in end-stage renal disease patients with sleep disorders. American Journal Kidney Disease, 35, 1052-1060.
9. Bleiberg, J., & Bunning, R. (1998). Cognitive and physical measures in rehabilitation of patients with lupus. Current Opinion Rheumatology, 10, 442-445.
10. Bombardier, C., Gladman, D.D., Urowitz, M.B., Caron, D., & Chang, C.H. (1992). Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis and Rheumatism, 35, 630-640.
11. Bosma, G.P.T., Rood, M.J., Huizinga, T.W.J., de Jong, B.A., Bollen, E.L.E.M., & van Buchem, M.A. (2000). Detection of cerebral involvement in patients with active neuropsychiatric systemic lupus erythematosus by the use of volumetric magnetization transfer imaging. Arthritis and Rheumatism, 43, 2428-2436.
12. Bruce, I.N., Mak, V.C., Hallett, D.C., Gladman, D.D., & Urowitz, M.B. (1999). Factors associated with fatigue in patients with systemic lupus erythematosus. Annals of the Rheumatic Diseases, 58, 379-381.
13. Carbotte, R., Denburg, S., & Denburg, J. (1986). Prevalence of cognitive impairment in systemic lupus erythematosus. Journal of Nervous and Mental Disorder, 174, 357-364.
14. Carbotte, R.M., Denburg, S.D., & Denburg, J.A. (1995a). Cognitive deficit associated with rheumatic diseases: Neuropsychological perspectives. Arthritis and Rheumatism, 38, 1363-1374.
15. Carbotte, R.M., Denburg, S.D., & Denburg, J.A. (1995b). Cognitive dysfunction in systemic lupus erythematosus is independent of active disease. The Journal of Rheumatology, 22, 863-867.
16. Carlomagno, S., Migliaresi, S., Ambrosone, L., Sannino, M., Sanges, G., & Di Iorio, G. (2000). Cognitive impairment in systemic lupus erythematosus: A follow-up study. Journal of Neurology, 247, 273-279.
17. Chang, D.M., Lan, J.L., Lin, H.Y., & Luo, S.F. (2002). Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: A multicenter randomized, double-blind, placebo-controlled trial. Arthritis and Rheumatism, 46, 2924-2927.
18. Cook, R.J., Gladman, D.D., Pericak, D., & Urowitz, M.B. (2000). Prediction of short mortality in systemic lupus erythematosus with time dependent measures of disease activity. Journal of Rheumatology, 27, 1892-1895.
19. DeGiorgio, L.A., Konstantinov, K.N., Lee, S.C., Hardin, J.A., Volle, B.T., & Diamond, B. (2001). A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nature Medicine, 7, 1189-1193.
20. Denburg, S., Carbotte, R., & Denburg, J. (1987). Cognitive impairment in systemic lupus erythematosus: A neuropsychological study of individual and group deficits. Journal of Clinical and Experimental Neuropsychology, 9, 323-339.
21. Denburg, S.D., Carbotte, R.M., & Denburg, J.A. (1997). Psychological aspects of systemic lupus erythematosus: Cognitive function, mood, and self-report. Journal of Rheumatology, 24, 998-1003.
22. Denburg, S.D., Carbotte, R.M., Ginsberg, J.S., & Denburg, J.A. (1997). The relationship of antiphospholipid antibodies to cognitive function in patients with systemic lupus erythematosus. Journal of the International Neuropsychological Society, 3, 377-386.
23. Denburg, S.D., Carbotte, R.M., Long, A.A., & Denburg, J.A. (1988). Neuropsychological correlates of serum lymphocytotoxic antibodies in systemic lupus erythematosus. Brain, Behavior, and Immunity, 2, 222-234.
24. Dinges, D.F., Douglas, S.D., Zaugg, L., Campbell, D.E., McMann, J.M., Whitehouse, W.G., Ome, E.C., Kapoor, S.C., Icaza, E., & Orne, M.T. (1994). Leukocytosis and natural killer cell function parallel neurobehavioral fatigue induced by 64 hours of sleep deprivation. The Journal of Clinical Investigation, 93, 1930-1939.
25. Dobkin, P.L., DaCosta, D., Dritsa, M., Fortin, P.R., Senecal, J.L., Goulet, L.R., Choquette, D., Rich, E., Beaulieu, A., Cividino, A., Edworthy, S., Barr, S., Ensworth, S., Esdaile, J.M., Gladman, D., Smith, D., Zummer, M., & Clarke, A.E. (1999). Quality of life in systemic lupus erythematosus patients during more and less active disease states: Differential contributors to mental and physical health. Arthritis Care and Research, 12, 401-410.
26. Dobkin, P.L., Fortin, P.R., Joseph, L., Esdaile, J.M., Danoff, D.S., & Clarke, A.E. (1998). Psychosocial contributors to mental and physical health in patients with systemic lupus erythematosus. Arthritis Care and Research, 11, 23-31.
27. Engleman, H.M., Kingshott, R.M., Wraith, P.K., Mackay, T.W., Deary, I.J., & Douglas, N.J. (1999). Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep Apnea/Hypopnea syndrome. American Journal Respiratory Critical Care Medicine, 159, 461-467.
28. Fortin, P.R., Abrahamowicz, M., Neville, C., du Berger, R., Clarke, A.E., & Danoff, D. (1998). Impact of disease activity and cumulative damage on the health of lupus patients. Lupus, 7, 101-107.
29. Gladman, D., Urowitz, M., Slonim, D., Glanz, B., Carlen, P., Noldy, N., Gough, J., Pauzner, R., Heslegrave, R., Darby, P., & MacKinnon, A. (2000). Evaluation of predictive factors for neurocognitive dysfunction in patients with inactive systemic lupus erythematosus. Journal of Rheumatology, 27, 2367-2371.
30. Gladman, D.D., Urowitz, M.B., Ong, A., Gough, J., & MacKinnon, A. (1996a). Lack of correlation among the 3 outcomes describing SLE: Disease activity, damage, and quality of life. Clinical and Experimental Rheumatology, 14, 305-308.
31. Gladman, D.D., Urowitz, M.B., Ong, A., Gough, J., & MacKinnon, A. (1996b). A comparison of five health status instruments in patients with systemic lupus erythematosus (SLE). Lupus, 5, 190-195.
32. Glanz, B., Slonim, D., Urowitz, M., Gladman, D., Gough, J., Math, M., & MacKinnon, A. (1997). Pattern of neuropsychological dysfunction in inactive systemic lupus erythematosus. Neuropsychiatry, Neuropsychology, and Behavioral Neurology, 10, 232-238.
33. Golbus, J., & McCune, W.J. (1987). Neuropsychiatric lupus: Clinical features, pathophysiology, diagnosis, and treatment. Internal Medicine, 8, 141-169.
34. Gordon, C., Exley, A.R., & Clay, C. (1997). Changes in SF-36 scores in SLE with change in disease activity measured by the BILAG index. Arthritis and Rheumatism, 40, S112.
35. Gudbjornsson, B., & Hetta, J. (2001). Sleep disturbances in patients with systemic lupus erythematosus: A questionnaire-based study. Clinical and Experimental Rheumatology, 19, 509-514.
36. Hanly, J., Cassell, K., & Fisk, J. (1997). Cognitive function in systemic lupus erythematosus: Results of a 5-year prospective study. Arthritis and Rheumatism, 40, 1542-1543.
37. Hanly, J., Hong, C., Smith, S., & Fisk, J. (1999). A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus. Arthritis and Rheumatism, 42, 728-734.
38. Hanly, J.G. (1997). Disease activity, cumulative damage and quality of life in systemic lupus erythematosus: Results of a cross-sectional study. Lupus, 6, 243-247.
39. Hanly, J.G., Fisk, J.D., Sherwood, G., & Eastwood, R. (1994). Clinical course of cognitive dysfunction in systemic lupus erythematosus. Journal of Rheumatology, 21, 1825-1831.
40. Harrison, M.J., & Ravdin, L.D. (2002). Cognitive dysfunction in neuropsychiatric lupus erythematosus. Current Opinion in Rheumatology, 14, 510-514.
41. Hay, E.M., Black, D., Huddy, A., Creed, F., Tomenson, B., Bernstein, R.M., & Lennox Holt, P.J. (1992). Psychiatric disorder and cognitive impairment in systemic lupus erythematosus. Arthritis and Rheumatism, 35, 411-416.
42. Hay, E.M., Huddy, A., Black, D., Mbaya, P., Tomenson, B., Bernstein, R.M., Lennox Holt, P.J., & Creed, F. (1994). A prospective study of psychiatric disorder and cognitive function in systemic lupus erythematosus. Annals of the Rheumatic Diseases, 53, 298-303.
43. Iverson, G. (1995). The need for psychological services for persons with Systemic Lupus Erythematosus. Rehabilitation Psychology, 40, 39-49.
44. Jimenez, S., Cervera, R., Font, J., & Ingelmo, M. (2003). The epidemiology of systemic lupus erythematosus. Clinical Reviews in Allergy and Immunology, 25, 3-12.
45. Kaposi, M. (1872). Neue beitrage zur Kenntnis des lupus erythematosus. Archiv fur Dermatologie und Syphilis, 4, 36-79.
46. Karassa, F.B., Ioannidis, J.P., Touloumi, G., Boki, K.A., & Moutsopoulos, H.M. (2000). Risk factors for central nervous system involvement in systemic lupus erythematosus. QJM: Monthly Journal of the Association of Physicians, 93, 169-174.
47. Karlson, E.W., Daltroy, L.H., Lew, R.A., Wright, E.A., Partridge, A.J., Fossel, A.H., Roberts, W.N., Stern, S.H., Straaton, K.V., Wacholtz, M.C., Kavanaugh, A.F., Grosflam, J.M., & Liang, M.H. (1997). The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus. Arthritis and Rheumatism, 40, 47-56.
48. Komatsu, N., Kodama, K., Yamanouchi, N., Okada, S., Noda, S., Nawato, U., Takabayashi, K., Iwamoto, I., Saito, Y., Uchida, Y., Ito, H., Yoshikawa, K., & Sato, T. (1999). Decreased regional cerebral metabolic rate for glucose in systemic lupus erythematosus patients with psychiatric symptoms. European Neurology, 42, 41-48.
49. Kozora, E., Laudenslager, M., Lemieux, A., & West, S.G. (2001). Inflammatory and hormonal measures predict neuropsychological functioning in systemic lupus erythematosus and rheumatoid arthritis patients. Journal of the International Neuropsychological Society, 7, 745-754.
50. Kozora, E., Thompson, L., West, S., & Kotzin, B. (1996). Analysis of cognitive and psychological deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis and Rheumatism, 39, 2035-2045.
51. Kozora, E., West, S., Kotzin, B., Julian, L., Porter, S., & Bigler, E. (1998). Magnetic resonance imaging abnormalities and cognitive deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis and Rheumatism, 41, 41-47.
52. Krupp, L.B., LaRocca, N.G., Muir, J., & Steinberg, A.D. (1990). A study of fatigue in systemic lupus erthyematosus. Journal of Rheumatology, 17, 1450-1452.
53. Kutner, K., Busch, H., Mahmood, T., Racis, S., & Krey, P. (1988). Neuropsychological functioning in systemic lupus erythematosus. Neuropsychology, 2, 119-126.
54. Leblhuber, F., Neubauer, C., Peichl, M., Reisecker, F., Steinparz, EX., Windhager, E., & Dienstl, E. (1993). Age and sex differences of dehydroepiandrosterone sulfate (DHEAS) and cortisol (CRT) plasma levels in normal controls and Alzheimer's disease (AD). Psychopharmacology, 111, 23-26.
55. Leritz, E., Brandt, J., Minor, M., Reis-Jensen, F., & Petri, M. (2002). Neuropsychological functioning and its relationship to antiphospholipid antibodies in patients with systemic lupus erythematosus. Journal of Clinical and Experimental Neuropsychology, 24, 527-533.
56. Liang, M.H., Socher, S.A., Roberts, W.N., & Esdaile, J.M. (1988). Measurement of systemic lupus erythematosus activity in clinical research. Arthritis and Rheumatism, 31, 817-825.
57. Loukkola, J., Laine, M., Ainiala, H., Peltola, J., Metsanoja, R., Auvinen, A., & Hietaharju, A. (2003). Cognitive impairment in systemic lupus erythematosus and neuropsychiatric systemic lupus erythematosus: A population-based neuropsychological study. Journal of Clinical and Experimental Neuropsychology, 25, 145-151.
58. Love, P., & Santoro, S. (1990). Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Annals of Internal Medicine, 112, 682-698.
59. McCune, W.J., & Golbus, J. (1988). Neuropsychiatric lupus. Rheumatic Disease Clinics of North America, 14, 149-167.
60. McKinley, P.S., Ouellette, S.C., & Winkel, G.H. (1995). The contributions of disease activity, sleep patterns, and depression to fatigue in systemic lupus erythematosus. A proposed model. Arthritis and Rheumatism, 38, 826-834.
61. Menon, A., Jameson-Shortall, E., Newman, S., Hall-Craggs, M., Chinn, R., & Isenberg, D. (1999). A longitudinal study, of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosus. Arthritis and Rheumatism, 42, 735-741.
62. Meurice, J.C., Paquereau, J., Denjean, A., Patte, F., & Series, F. (1998). Influence of correction of flow limitation on continuous positive airway pressure efficiency in sleep apnoea/hypopnoea syndrome. The European Respiratory Journal: Official Journal of the European Society for Clinical Respiratory Physiology, 11, 1121-1127.
63. Moldofsky, H., Scarisbrick, P., England, R., & Smythe, H. (1975). Musculosketal symptoms and non-REM sleep disturbance in patients with "fibrositis syndrome" and healthy subjects. Psychosomatic Medicine, 37, 341-351.
64. Molenaar, E., van der Heijde, D., & Boers, M. (2000). Update on outcome assessment in rheumatic disorders. Current Opinion in Rheumatology, 12, 91-98.
65. Monastero, R., Bettini, P., Del Zotto, E., Cottini, E., Tincani, A., Balestieri, G., Catteneo, R., Camarda, R., Vignolo, L., & Padovani, A. (2001). Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations. Journal of the Neurological Sciences, 184, 33-39.
66. Montplaisir, J., Boucher, S., Gosselin, A., Poirer, G., & Lavigne, G. (1996). Persistence of repetitive EEG arousals (K-alpha complexes) in RLS patients treated with L-DOPA. Sleep, 19, 196-199.
67. Nyenhuis, D., Rao, S., Zajecka, J., Luchetta, T., Bemardin, L., & Garron, D. (1995). Mood disturbance versus other symptoms of depression in multiple sclerosis. Journal of the International Neuropsychological Society, 1, 291-296.
68. Omdal, R., Mellgren, S.I., Koldingsnes, W., Jacobsen, E.A., & Husby, G. (2002). Fatigue in patients with systemic lupus erythematosus: Lack of associations to serum cytokines, antiphospholipid antibodies, or other disease characteristics. The Journal of Rheumatology, 29, 482-486.
69. Ozturk, L., Pelin, Z., Karadeniz, D., Kaynak, H., Cakar, L., & Gozukirmizi, E. (1999). Effects of 48 hours sleep deprivation on human immune profile. Sleep Research Online, 2, 107-111.
70. Pincus, T., Swearingen, C., & Wolfe, F. (1999). Toward a multidimensional Health Assessment Questionnaire (MDHAQ): Assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire format. Arthritis and Rheumatism, 42, 2220-2230.
71. Posner, M.I., & Petersen, S.E. (1990). The attention system of the human brain. Annual Review of Neuroscience, 13, 25-42.
72. Puente, A.E., & McCaffrey, R.J. (Eds.). (1992). Handbook of neuropsychological assessment: A biopsychosocial perspective. New York: Plenum Press.
73. Purandare, K.N., Wagle, A.C., & Parker, S.R. (1999). Psychiatric morbidity in patients with systemic lupus erythematosus. Quarterly Journal of Medicine, 92, 283-286.
74. Redwine, L., Hauger, R.L., Gillin, J.C., & Irwin, M. (2000). Effects of sleep and sleep deprivation on interleukin-6, growth hormone, cortisol, and melatonin levels in humans. The Journal of Clinical Endocrinology and Metabolism, 85, 3597-3603.
75. Roehrs, T., Merrion, M., Pedrosi, B., Stepanski, E., Zorick, F., & Roth, T. (1995). Neuropsychological function in obstructive sleep apnea syndrome (OSAS) compared to chronic obstructive pulmonary disease (COPD). Sleep, 18, 382-388.
76. Rozensky, R., Sweet, J., & Tovian, S. (1997). Psychological assessment in medical settings. New York: Plenum.
77. Sailer, M., Burchert, W., Ehrenheim, C., Smid, H., Haas, J., Wildhagen, K., Wurster, U., & Deicher, H. (1997). Positron emission tomography and magnetic resonance imaging for cerebral involvement in patients with systemic lupus erythematosus. Journal of Neurology, 244, 186-193.
78. Segui, J., Ramos-Casals, M., Garcia-Carrasco, M., de Flores, T., Cervera, R., Valdes, M., Font, J., & Ingelmo, M. (2000). Psychiatric and psychosocial disorders in patients with systemic lupus erythematosus: A longitudinal study of active and inactive stages of the disease. Lupus, 9, 584-588.
79. Shearer, W.T., Reuben, J.M., Mullington, J.M., Price, N.J., Lee, B.N., Smith, E.O., Szuba, M.P., Van Dongen, H.P., & Dinges, D.F. (2001). Soluble TNF-alpha receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight. The Journal of Allergy and Clinical Immunology, 107, 165-170.
80. Shiozawa, S., Kuroki, Y., Kim, M., Hirohata, S., & Ogino, T. (1992). Interferon-alpha in lupus psychosis. Arthritis and Rheumatism, 35, 417-422.
81. Sibbitt, W., Jung, R., & Brooks, W. (1999). Neuropsychiatric systemic lupus erythematosus. Comprehensive Therapy, 25, 198-208.
82. Skeel, R., Johnstone, B., Yangco, D., Walker, S., & Komatireddy, G. (2000). Neuropsychological deficit profiles in systemic lupus erythematosus. Applied Neuropsychology, 7, 96-101.
83. Smolen, J.S., Strand, V., Cardiel, M., Edworthy, S., Furst, D., Gladman, D., Gordon, C., Isenberg, D.A., Klippel, J.H., Petri, M., Simon, L., Tugwel, P., & Wolfe, F. (1999). Randomized clinical trials and longitudinal observational studies in systemic lupus erythematosus: Consensus on a preliminary core set of outcome domains. Journal of Rheumatology, 26, 504-507.
84. Stoll, T., Gordon, C., Seifert, B., Richardson, K., Malik, J., Bacon, P.A., & Isenberg, D.A. (1997). Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus. Journal of Rheumatology, 24, 1608-1614.
85. Strand, V., Gladman, D., Isenberg, D., Petri, M., Smolen, J., & Tugwell, P. (1999). Outcome measures to be used in clinical trials in systemic lupus erythematosus. Journal of Rheumatology, 26, 490-497.
86. Sweet, J., & Westergaard, C. (1997). Evaluation of psychopathology in neuropsychological assessment. In G. Goldstein & T. Incagnoli (Eds.), Contemporary approaches in neuropsychological assessment. New York: Plenum.
87. Symmons, D.P., Coppock, J.S., Bacon, P.A., Bresnihan, B., Isenberg, D.A., Maddison, P., McHugh, N., Snaith, M.L., & Zoma, A.S. (1988). Development and assessment of a computerized index of clinical disease activity in systemic lupus erythematosus. Members of the British Isles Lupus Assessment Group (BILAG). The Quarterly Journal of Medicine, 69, 927-937.
88. Tayer, W.G., Nicassio, P.M., Weisman, M.H., Schuman, C., & Daly, J. (2001). Disease status predicts fatigue in systemic lupus erythematosus. The Journal of Rheumatology, 28, 1999-2007.
89. Tench, C., McCurdie, I., White, P., & D'Cruz, D. (2000). The prevalence and associations of fatigue in systemic lupus erythematosus. Rheumatology, 39, 1249-1254.
90. Traynor, A.E., Schroeder, J., Rosa, R.M., Cheng, D., Stefka, J., Mujais, S., Baker, S., & Burt, R.K. (2000). Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: A phase I study. Lancet, 356, 701-707.
91. Turkel, S., Miller, J., & Reiff, A. (2001). Case series: Neuropsychiatric symptoms with pediatric systemic lupus erythematosus. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 482-485.
92. Valencia-Flores, M., Resendiz, M., Castano, V.A., Santiago, V., Campos, R.M., Sandino, S., Valencia, X., Alcocer, J., Ramos, G.G., & Bliwise, D.L. (1999). Objective and subjective sleep disturbances in patients with systemic lupus erythematosus. Arthritis and Rheumatism, 42, 2189-2193.
93. Verstraeten, E., Cluydts, R., Verbraecken, J., & De Roeck, J. (1996). Neuropsychological functioning and determinants of morning alertness in patients with obstructive sleep apnea syndrome. Journal of the International Neuropsychological Society, 2, 306-314.
94. Wang, B., Gladman, D.D., & Urowitz, M.B. (1998). Fatigue in lupus is not correlated with disease activity. Journal of Rheumatology, 25, 892-895.
95. Wang, C., Mayo, N.E., & Fortin, P.R. (2001). The relationship between health related quality of life and disease activity and damage in systemic lupus erythematosus. Journal of Rheumatology, 28, 525-532.
96. Ward, M.M., Marx, A.S., & Barry, N.N. (2002). Psychological distress and changes in the activity of systemic lupus erythematosus. Rheumatology, 41, 184-188.
97. Ware, J.E. (1987). Standards for validating health measures: Definition and content. Journal of Chronic Disease, 40, 473-480.
98. Waterloo, K., Omdal, R., Mellgren, S., & Husby, G. (1997). Neuropsychological functions in systemic lupus erythematosus: A comparison with chronic whiplash patients. European Journal of Neurology, 4, 171-177.
99. Waterloo, K., Omdal, R., Jacobsen, E.A., Klow, N.E., Husby, G., Torbergsen, T., & Mellgren, S.I. (1999). Cerebral computed tomography and electroencephalography compared with neuropsychological findings in systemic lupus erythematosus. Journal of Neurology, 246, 706-711.
100. Waterloo, K., Omdal, R., Sjoholm, H., Koldingsnes, W., Jacobsen, E.A., Sundsfjord, J.A., Husby, G., & Mellgren, S.I. (2001). Neuropsychological dysfunction in systemic lupus erythematosus is not associated with changes in cerebral blood flow. Journal of Neurology, 248, 595-602.
101. Weiner, S.M., Otte, A., Schumacher, M., Klein, R., Gutfleisch, J., Brink, I., Otto, P., Nitzsche, E.U., Moser, E., & Peter, H.H. (2000). Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: Value of F-18 fluorodeoxyglucose PET. Annals of the Rheumatic Diseases, 59, 377-385.
102. Wetter, T.C., & Pollmacher, T. (1997). Restless legs and periodic leg movements in sleep syndromes. Journal of Neurology, 244, S37-S45.
103. Whitelaw, D., Spangenberg, J., Rickman, R., Hugo, F., & Roberts, M. (1999). The association between the antiphospholipid antibody syndrome and neuropsychological impairment in SLE. Lupus, 8, 444-448.
104. Wilson, I.B., & Cleary, P.D. (1995). Linking clinical variables with health-related quality of life: A conceptual model of patient outcomes. Journal of the American Medical Association, 273, 59-65.
105. Wysenbeek, A.J., Leibovici, L., Weinberger, A., & Guedj, D. (1993). Fatigue in systemic lupus erythematosus. Prevalence and relation to disease expression. British Journal of Rheumatology, 32, 633-635.
106. Zapor, M., Rennie, T., Murphy, F., & Battafarano, D. (2000). Clinical images: Neuropsychiatric systemic lupus erythematosus. Arthritis and Rheumatism, 43, 2045.
107. Zonana-Nacach, A., Roseman, J.M., McGwin, G., Friedman, A.W., Baethge, B.A., Reveille, J.D., & Alarcon, G.S. (2000). Systemic lupus erythematosus in three ethnic groups. VI: Factors associated with fatigue within 5 years of criteria diagnosis. LUMINA study group. Lupus in Minority populations: Nature vs. Nurture. Lupus, 9, 101-109.